Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Ribozyme Pharmaceuticals Incorporated

Ribozyme Pharmaceuticals was founded to develop commercial products and services based upon the significant potential of "ribozymes," a discovery of Professor Thomas R. Cech for which he shared a Nobel Prize. Ribozymes, a form of ribonucleic acid ("RNA"), can selectively inhibit the protein production and genetic function associated with a specific messenger RNA ("mRNA") molecule by binding with the particular mRNA and cutting it apart. Ribozymes treat humandisease in two primary ways. First, ribozymes can be designed to inhibit abnormal gene function that causes a disease or is essential to the growth or spread of the disease. Second, ribozymes can be designed to target viruses and other infectious agents causing disease in humans. Ribozymes also are useful in identifying the function of specific genes (validating targets) and in diagnosing disease. Ribozymes can also be designed to treat animal diseases and alter traits of plants.


Contact Details:
2950 Wilderness Place
Boulder
CO
80301
United States of America
Tel:303 449 6500
Fax:303 449 6995
Email:
WWW:

www.rpi.com/




Loading...

Recent Publications by Ribozyme Pharmaceuticals Incorporated:

Oligoribonucleotides with 2'-O-(tert-butyldimethylsilyl) groups.
The chemical synthesis of oligoribonucleotides on solid support is...
15th May, 2008
Ribozyme Pharmaceuticals, Boulder, Colorado, USA. Curr Protoc Nucleic Acid Chem. 2001 May;Chapter 3:Unit 3.6.
DOI Direct Link
Strategies for oligoribonucleotide synthesis according to the phosphoramidite method.
Advances in oligoribonucleotide synthesis have lagged behind those in...
15th May, 2008
Ribozyme Pharmaceuticals, Inc., Boulder, Colorado, USA. Curr Protoc Nucleic Acid Chem. 2001 May;Chapter 3:Unit 3.5.
DOI Direct Link
Synthesis of 1,4-anhydro-2-deoxy-D-ribitol derivatives from thymidine.
1,2-Dideoxyribose 5-O-succinate, a component of solid support employed in...
12th December, 2003
Ribozyme Pharmaceuticals Inc., Boulder, Colorado 80301, USA. Nucleosides Nucleotides Nucleic Acids. 2003 May-Aug;22(5-8):1305-7.
Synthesis of 2'-O-substituted ribonucleosides.
An efficient synthesis of 2'-O-substituted ribonucleosides, including...
12th December, 2003
Ribozyme Pharmaceuticals Inc., Boulder, Colorado 80301, USA. Nucleosides Nucleotides Nucleic Acids. 2003 May-Aug;22(5-8):1007-9.
Scaleable and efficient synthesis of 2'-deoxy-2'-N-phthaloyl nucleoside phosphoramidites for oligonucleotide synthesis.
2'-Deoxy-2'-N-phthaloyl nucleosides were prepared from arabino nucleosides...
13th November, 2003
Department of Chemistry and Biochemistry, Ribozyme Pharmaceuticals Inc., Bioorg Med Chem Lett. 2002 Nov 18;12(22):3345-7.

View more Ribozyme Pharmaceuticals Incorporated research publications.

BioNews Results for Ribozyme Pharmaceuticals Incorporated:

NUCRYST Announces Special Meeting of Shareholders
Pharma Live:  Nov 23 2009 2:59AM Matching: pharmaceuticals
NUCRYST Announces Special Meeting of Shareholders
KLFY:  Nov 22 2009 12:21AM Matching: pharmaceuticals
Alnylam Pharmaceuticals Down 21.5% Since SmarTrend's Sell Recommendation
TradingMarkets:  Nov 21 2009 7:26PM Matching: pharmaceuticals
NUCRYST Announces Special Meeting of Shareholders
TickerTech.com:  Nov 21 2009 8:43PM Matching: pharmaceuticals
NUCRYST Announces Special Meeting of Shareholders
KSLA:  Nov 21 2009 7:19PM Matching: pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more Ribozyme Pharmaceuticals Incorporated news.

Ribozyme Pharmaceuticals Incorporated Patents:

US Patent No.Title
6103890 Enzymatic nucleic acids that cleave C-fos
6251666 Nucleic acid catalysts comprising L-nucleotide analogs
6258585 Method and reagent for inhibiting influenza virus replication
6268534 Process for the synthesis of N,N-Dioleyl-N,N-Dimethylammonium Chloride
6280936 Method for screening nucleic acid catalysts

View more Ribozyme Pharmaceuticals Incorporated patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 13 individuals from Ribozyme Pharmaceuticals Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 607 times since April 2007, the link to the organisation's website has been followed 146 times

Recent Search Terms used to find this page: ribozyme pharmaceuticals | ribozyme pharmaceuticals founder | Ribozyme Pharmaceuticals | Ribozyme Pharmaceuticals | RibozymePharmaceuticals | recent searches about ribozymes | Ribozyme Pharmaceuticals | ribozyme pharmaceuticals | ribozyme pharmaceuticals | Ribozyme Pharmaceuticals | .

Search for more companies in Boulder

Search for more companies in CO



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Ribozyme Pharmaceuticals Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.